KRRO
Korro Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.35
−12.29%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 146.31x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.48x
- Price / sales
- 63.98x
- Price / cash flow
- -2.24x
Enterprise value
- Enterprise value
- $79.6M
- EV / sales
- 33.41x
- EV / EBITDA
- -1.11x
- EV / EBIT
- -1.05x
- Market cap
- $152.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026